Area of research
Epidemiology · Health, Toxicology and Mutagenesis
Research interest
Research interests include Respiratory viral infections research, Environmental Toxicology and Ecotoxicology, Viral gastroenteritis research and epidemiology, and Viral Infections and Immunology Research.
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic.
High Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted to the Pediatric University Hospital Complex in Bangui, Central African Republic
Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic
Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic
Very High Relative Seroprevalence of Anti--SARS-CoV-2 Antibodies Among Communities in Bangui, Central African Republic
Precision Public Health Through Serological Biomarkers: An Integrated Surveillance Platform to Inform Public Health Interventions
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries
Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia
Multicenter case–control study protocol of pneumonia etiology in children: Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL network)
High Incidence of Treatment-Induced And Vaccine-Escape Hepatitis B Virus Mutants Among Human Immunodeficiency Virus/Hepatitis B–Infected Patients